RecruitingNCT06642831
Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study
Polycystic Ovarian Syndrome (PCOS) in Human Adolescent and Young Adult Females - Biomarker Evaluation Study (PHOEBE)
Sponsor
University Hospital Erlangen
Enrollment
380 participants
Start Date
Jan 31, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women.
Eligibility
Sex: FEMALEMin Age: 15 YearsMax Age: 25 Years
Plain Language Summary
Simplified for easier understanding
This study is looking for blood and hormonal biomarkers (biological indicators) that can help diagnose and monitor polycystic ovary syndrome (PCOS) in young women.
**You may be eligible if...**
- You are a female between 15 and 25 years old
- You are willing to sign a consent form
**You may NOT be eligible if...**
- It has been less than 1 year since you had your first period
- You are using hormonal contraceptives
- You are currently pregnant
- You have major ovarian cysts or masses larger than 2 cm, or you only have one ovary
- You have or are being treated for a cancer
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06642831